Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04144114 · ClinicalTrials.gov registry record · NA
The Effect of ProHydrolase® on the Amino Acid, Intramuscular Anabolic Signaling, and Endocrine Response to Resistance Exercise in Trained Males
A NA study, sponsored by Deerland Enzymes.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT04144114 is a NA study that has completed, run by Deerland Enzymes. The registered enrollment target is 10 participants.
The verdict
NCT04144114, a NA study, has completed, sponsored by Deerland Enzymes.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
To examine the amino acid absorption following acute resistance exercise between three supplemental treatments: 1) Whey Protein + ProHydrolase (WPH) 2) Whey Protein (W) and 3) Non-Caloric Placebo (PL). To examine three supplemental treatments (WPH, W, PL) in conjunction with acute resistance exercise on the mTORC1 complex pathway. To examine three supplemental treatments (WPH, W, PL) in conjunction with acute resistance exercise on circulating concentrations of endocrine biomarkers.
Interventions
- DIETARY_SUPPLEMENT Placebo
- DIETARY_SUPPLEMENT Whey protein
- DIETARY_SUPPLEMENT ProHydrolase®
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2018-12-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04144114
The ClinicalTrials.gov registry entry for NCT04144114 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Deerland Enzymes, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT04144114 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04144114 about?
NCT04144114 is a clinical study titled "The Effect of ProHydrolase® on the Amino Acid, Intramuscular Anabolic Signaling, and Endocrine Response to Resistance Exercise in Trained Males". To examine the amino acid absorption following acute resistance exercise between three supplemental treatments: 1) Whey Protein + ProHydrolase (WPH) 2) Whey Protein (W) and 3) Non-Caloric Placebo (PL). To examine three supplemental treatments (WPH, W, PL) in conjunction with acute resistance exercis...
What is the current status of trial NCT04144114?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2018-08-01. Estimated completion is 2018-12-07.
What interventions are being tested in trial NCT04144114?
The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), Whey protein (DIETARY_SUPPLEMENT), ProHydrolase® (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT04144114?
This trial is sponsored by Deerland Enzymes, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.